Avinger (AVGR) Competitors

$3.93
+0.13 (+3.42%)
(As of 05/13/2024 ET)

AVGR vs. INBS, VVOS, VAPO, TMDIF, VERO, OSA, STSS, AFIB, GMVDF, and AEMD

Should you be buying Avinger stock or one of its competitors? The main competitors of Avinger include Intelligent Bio Solutions (INBS), Vivos Therapeutics (VVOS), Vapotherm (VAPO), Titan Medical (TMDIF), Venus Concept (VERO), ProSomnus (OSA), Sharps Technology (STSS), Acutus Medical (AFIB), G Medical Innovations (GMVDF), and Aethlon Medical (AEMD). These companies are all part of the "surgical & medical instruments" industry.

Avinger vs.

Avinger (NASDAQ:AVGR) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, community ranking, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

Avinger presently has a consensus target price of $5.00, indicating a potential upside of 25.94%. Given Avinger's higher possible upside, research analysts plainly believe Avinger is more favorable than Intelligent Bio Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avinger
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Intelligent Bio Solutions
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Avinger has a net margin of -239.41% compared to Intelligent Bio Solutions' net margin of -354.86%. Avinger's return on equity of 0.00% beat Intelligent Bio Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
Avinger-239.41% N/A -106.16%
Intelligent Bio Solutions -354.86%-210.36%-89.33%

Avinger received 393 more outperform votes than Intelligent Bio Solutions when rated by MarketBeat users.

CompanyUnderperformOutperform
AvingerOutperform Votes
393
59.64%
Underperform Votes
266
40.36%
Intelligent Bio SolutionsN/AN/A

18.3% of Avinger shares are held by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are held by institutional investors. 11.4% of Avinger shares are held by insiders. Comparatively, 0.3% of Intelligent Bio Solutions shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Intelligent Bio Solutions has lower revenue, but higher earnings than Avinger. Avinger is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avinger$7.65M0.83-$18.32M-$26.34-0.15
Intelligent Bio Solutions$1.26M5.84-$10.63M-$38.91-0.06

In the previous week, Intelligent Bio Solutions had 2 more articles in the media than Avinger. MarketBeat recorded 7 mentions for Intelligent Bio Solutions and 5 mentions for Avinger. Avinger's average media sentiment score of 0.79 beat Intelligent Bio Solutions' score of 0.65 indicating that Avinger is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avinger
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Intelligent Bio Solutions
1 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Avinger has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.87, indicating that its stock price is 387% more volatile than the S&P 500.

Summary

Avinger beats Intelligent Bio Solutions on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVGR vs. The Competition

MetricAvingerSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$6.31M$3.80B$4.86B$7.79B
Dividend YieldN/A2.01%38.86%3.93%
P/E Ratio-0.159.55125.8615.00
Price / Sales0.8368.712,404.4076.78
Price / CashN/A46.4732.0828.46
Price / Book-0.884.204.944.53
Net Income-$18.32M$4.41M$101.44M$216.00M
7 Day Performance4.20%-0.69%2.14%0.75%
1 Month Performance-7.35%0.28%1.93%2.59%
1 Year Performance-46.53%7.85%7.80%12.49%

Avinger Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INBS
Intelligent Bio Solutions
0.3572 of 5 stars
$2.89
+16.5%
N/A-93.0%$7.05M$2.46M-0.0351Short Interest ↑
VVOS
Vivos Therapeutics
0 of 5 stars
$2.43
+2.1%
N/A-74.1%$7.24M$13.80M-0.22114Short Interest ↓
News Coverage
VAPO
Vapotherm
0 of 5 stars
$1.19
flat
N/A-76.6%$7.38M$68.67M-0.12182Earnings Report
Gap Down
TMDIF
Titan Medical
0 of 5 stars
$0.04
flat
N/A-75.6%$4.56M$17.63M1.004News Coverage
VERO
Venus Concept
0.956 of 5 stars
$0.69
+3.0%
N/AN/A$4.36M$76.35M-0.10304Upcoming Earnings
Short Interest ↑
News Coverage
Gap Down
OSA
ProSomnus
1.5863 of 5 stars
N/A$2.33
+∞
-99.4%$8.18M$27.65M-0.30136News Coverage
Gap Down
STSS
Sharps Technology
1.796 of 5 stars
$0.24
-4.0%
N/A-77.7%$3.76MN/A0.0057Short Interest ↓
Gap Down
AFIB
Acutus Medical
0 of 5 stars
$0.12
+19.4%
N/A-95.3%$3.66M$7.16M-0.10230Earnings Report
Short Interest ↓
Gap Down
High Trading Volume
GMVDF
G Medical Innovations
0 of 5 stars
$0.01
flat
N/AN/A$3.38M$4.42M0.0084Gap Down
AEMD
Aethlon Medical
1.4841 of 5 stars
$1.28
-2.3%
$10.00
+681.3%
-63.1%$3.35M$570,000.00-0.2615Short Interest ↑
News Coverage

Related Companies and Tools

This page (NASDAQ:AVGR) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners